Journal List > Korean J Gastroenterol > v.68(4) > 1007564

Heo, Hong, Kim, Moon, Yang, Park, Park, Choi, Kim, Yoon, Cho, and Oh: The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess: A Prospectively Enrolled Cross-sectional Study

Abstract

Background/Aims

Several studies suggest that pyogenic liver abscess (PLA) is associated with colon neoplasm. A colonoscopic exam for cryptogenic PLA might detect a hidden colon neoplasm, through which intestinal flora can be transmitted into the liver. However, there are no prospectively enrolled cross-sectional data for colonic neoplasm in cryptogenic PLA.

Methods

Patients with PLA were prospectively enrolled from two university hospitals. Among them, all the patients with cryptogenic PLA were recommended for colonoscopic exam to check for colonic neoplasm.

Results

One hundred eighty-three patients with PLA were enrolled in the study for 22 months. One hundred and one (55.2%) patients did not have a definite cause of liver abscess at initial evaluation. The median diameter of the largest lesion was 5.7 cm (1.0–14.0 cm), and 74.3% of the patients were treated by percutaneous abscess drainage. Ninety-one percent of the patients who had an identified pathogen yielded Klebsiella. Sixty-two patients underwent colonoscopic exams, and no one had a colonic cancer, one had an adenomatous polyp with high grade dysplasia (1.6%), and 27 had adenomatous polyps with low grade dysplasia (43.5%; 41.0% in male and 43.5% in female). Of fifty patients who underwent an esophagogastroduodenoscopic exam, nine had gastric ulcers, one had an esophageal ulcer, and one had hemorrhagic gastritis.

Conclusions

The prevalence of colonic neoplasm among the patients with cryptogenic PLA was not as high as that in previous studies. Further well-designed, large-scale studies are required to assess the association of the colon neoplasm and cryptogenic PLA.

References

1. Jeong SW, Jang JY, Lee TH, et al. Cryptogenic pyogenic liver abscess as the herald of colon cancer. J Gastroenterol Hepatol. 2012; 27:248–255.
crossref
2. Koo HC, Kim YS, Kim SG, et al. Should colonoscopy be performed in patients with cryptogenic liver abscess? Clin Res Hepatol Gastroenterol. 2013; 37:86–92.
crossref
3. Lai HC, Lin HC. Cryptogenic pyogenic liver abscess as a sign of colorectal cancer: a population-based 5-year follow-up study. Liver Int. 2010; 30:1387–1393.
crossref
4. Kim AY, Chung RT. Bacterial, parasitic, and fungal infections of the liver, including liver abscess. Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran's gastrointestinal and liver disease. 10th ed.Philadelphia, PA: Saunders;2016. p. 1374–1392.
crossref
5. Antia FP, Marker F. Hepatic abscess secondary to duodenal ulcer. Lancet. 1955; 268:649–650.
crossref
6. Heo NY, Park SH, Park J, et al. Pyogenic liver abscess with complicating intestinal tuberculosis. J Med Cases. 2013; 3:370–372.
crossref
7. Knowels R, Rinaldo JA. Pyogenic liver abscess probably secondary to sigmoid diverticulitis: report of two cases. Gastroenterology. 1960; 38:262–266.
8. Margalit M, Elinav H, Ilan Y, Shalit M. Liver abscess in inflammatory bowel disease: report of two cases and review of the literature. J Gastroenterol Hepatol. 2004; 19:1338–1342.
crossref
9. Song J, Swekla M, Colorado P, Reddy R, Hoffmann S, Fine S. Liver abscess and diarrhea as initial manifestations of ulcerative colitis: case report and review of the literature. Dig Dis Sci. 2003; 48:417–421.
10. Cancer incidence according to the age group. [Internet]. Goyang: National Cancer Information Center; [updated 2015 Dec 23;cit-ed 2016 Jul 17]. Available from:. http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040103000000.
11. Lai HC, Lin CC, Cheng KS, et al. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study. Gastroenterology. 2014; 146:129–137.e1.
crossref
12. Yang MH, Rampal S, Sung J, et al. The prevalence of colorectal adenomas in asymptomatic Korean men and women. Cancer Epidemiol Biomarkers Prev. 2014; 23:499–507.
crossref
13. Jung HG, Kim DH, Lee CH. A case of subcapsular liver abscess secondary to perforating ulcer of gastric cancer. Korean J Gastroenterol. 2010; 56:109–113.
crossref
14. Okuno M, Adachi S, Nakamura N, et al. A case of advanced gastric cancer with liver abscesses. Nihon Shokakibyo Gakkai Zasshi. 2013; 110:869–874.
15. Sakata T, Narita M, Ohtani N, et al. A case of phlegmonous gastritis with multiple liver and splenic abscesses. Nihon Shokakibyo Gakkai Zasshi. 2011; 108:50–58.
16. Lin JN, Lin CL, Lin MC, Lai CH, Lin HH, Kao CH. Pyogenic liver abscess in patients with inflammatory bowel disease: a nationwide cohort study. Liver Int. 2016; 36:136–144.
crossref

Fig. 1.
Colonoscopic findings for the patients with cryptogenic pyogenic liver abscess. PLA, pyogenic liver abscess; CFS, colonoscopy; LGD, low grade dysplasia; HGD, high grade dysplasia.
kjg-68-195f1.tif
Table 1.
Pyogenic Liver Abscess Etiologies
Causes Liver abscess (n=183)
Cryptogenic 101 (55.2)
Biliary a 71 (38.8)
Gastrointestinal b 2 (1.1)
Others c 9 (4.9)

Values are presented as n (%).

a Cholangitis due to bile duct stone or previous biliary operation.

b One patient had a microperforation of the stomach, the other had a stomach cancer.

c Six patients had a post-TACE hepatic infarction, and the other three had a complicated hepatic cyst, a liver metastasis of gastric cancer, and hepatocellular carcinoma.

Table 2.
Baseline Characteristics of Patients with Cryptogenic Pyogenic Liver Abscess
Characteristic Cryptogenic liver abscess (n=101)
Age (yr) 62 (20–94)
Male 64 (63.4)
White blood cell (/mm3) 13,190 (1,950–36,480)
Hemoglobin (g/dL) 12.3 (8.4–16.6)
Platelet (/mm3) 170,000 (9,000–759,000)
AST (IU/L) 63 (15–4,336)
ALT (IU/L) 66 (11–1,685)
ALP (IU/L)  
 Hospital 1 a 331 (120–2,201)
 Hospital 2, phase I b 457 (181–2,093)
 Hosptial 2, phase II b 172 (37–1,293)
GGT (IU/L) 100 (17–831)
Total bilirubin (mg/dL) 1.0 (0.2–6.6)
Albumin (g/dL) 3.2 (2.0–4.6)
Creatinine (mg/dL) 0.89 (0.40–5.65)
Glucose (mg/dL) 132 (74–503)
PT INR 1.19 (0.95–3.22)
CRP (mg/dL) 17.8 (0.5–40.9)
HBsAg c (%) 6 (6.1)
Anti-HCV c (%) 0
Anti-HIV c (%) 0
Diabetes mellitus 38 (37.6)
Immune suppressant use 1 (1.0)
Colonoscopic procedure within 1 month 1 (1.0)
Number of abscess pockets  
 1 75 (74.3)
 2 18 (17.8)
 3 4 (4.0)
 ≥4 4 (4.0)
Maximal diameter of largest lesion (cm) 5.7 (1.0–14.0)
Percutaneous drainage use 75 (74.3)

Values are presented as median (range) or n (%).

a Hospital 1 is Inje University Haeundae Paik Hospital, in which the reference range of ALP is 104–338 IU/L.

b Hospital 2 is Pusan National Universtiy Yangsan Hospital, in which the reference range of ALP was changed into phase I (95–280 IU/L) and II (30–120 IU/L) before and after March 1, 2015, respectively.

c Missing data is 3, 3, and 8 in HBsAg, anti-HCV, and anti-HIV, respectively.

Table 3.
Esophagogastroduodenoscopic Findings for Cryptogenic Pyogenic Liver Abscess Patients
Endoscopic finding Patient (n=50)
Normal 10 (20.0)
Gastric ulcer 9 (18.0)
Atrophic gastritis±intestinal metaplasia 20 (40.0)
Erosive gastritis 4 (8.0)
Erythematous gastritis 6 (12.0)
Gastric polyp or adenoma 3 (6.0)
Hemorrhagic gastritis 1 (2.0)
Ampullary adenoma 1 (2.0)
Esophageal ulcer 1 (2.0)
Reflux esophagitis, LA-A 1 (2.0)

Values are presented as n (%).

Three cases had atrophic gastritis with erosive gastritis, and one had atrophic gastritis with nonspecific esophageal ulcer.

Table 4.
Causative Bacteria of Cryptogenic Pyogenic Liver Abscess (PLA)
Bacteria Cryptogenic PLA (n=101) PLA with known cause (n=82)
No growth 31 (30.7) 33 (40.2)
Klebsiella a 63 (62.4) 22 (26.8)
Streptococcus 3 b (2.9) 6 c (7.3)
Escherichia coli 1 (1.0) 14 (17.1)
Enterobacter 1 (1.0) 4 (4.9)
Pseudomonas 1 (1.0)  
Gemella morbillorum 1 (1.0)  
Enterococcus   16 (19.5)
Proteus   2 (2.4)
Citrobacter   2 (2.4)
Serratia   1 (1.2)
Provotella   1 (1.2)
Shewanella   1 (1.2)

Among the patients with PLA with known cause, 8 had 2 pathogens, 5 had 3 pathogens, 1 had 4 pathogens.

a One patient presented Klebsiella oxytoca, and those remaining had K. pneumoniae.

b This group included Streptococcus gordonii, S. sanguis, and S. constellatus ssp. pharyngis.

c This group included S. anginosus, S. sanguinis, S. intermedius, and viridans streptococci.

TOOLS
Similar articles